Development of Novavax’s combined flu and COVID-19 vaccine faces setback as FDA suspends clinical trials
Related media - Recent news Novavax recently announced that the FDA has suspended clinical trials for its combined influenza and COVID-19 vaccine. This development represents a setback to the company's…










